RADEK SKODA to Polycythemia
This is a "connection" page, showing publications RADEK SKODA has written about Polycythemia.
Connection Strength
1.500
-
A Gain-of-Function Mutation in EPO in Familial Erythrocytosis. N Engl J Med. 2018 03 08; 378(10):924-930.
Score: 0.559
-
JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis. Blood. 2016 08 11; 128(6):839-51.
Score: 0.496
-
Identification of Hepatic-like EPO as a Cause of Polycythemia. N Engl J Med. 2025 May 01; 392(17):1684-1697.
Score: 0.230
-
Erythropoietin receptor mutation--a rush of blood to the head? Ann Hematol. 2015 Jul; 94(7):1229-31.
Score: 0.114
-
Chronic myeloproliferative disorders: molecular markers and pathogenesis. Hematol J. 2004; 5 Suppl 3:S122-5.
Score: 0.052
-
Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging. J Thromb Haemost. 2014 Dec; 12(12):2120-30.
Score: 0.028
-
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood. 2011 Mar 10; 117(10):2813-6.
Score: 0.021